CN214915914U

CN214915914U - Aerosol generating system and inflammation therapeutic apparatus

Info

Publication number: CN214915914U
Application number: CN202023332263.2U
Authority: CN
Inventors: 林金明; 林海锋
Original assignee: Tsinghua University
Current assignee: Tsinghua University
Priority date: 2020-12-30
Filing date: 2020-12-30
Publication date: 2021-11-30
Anticipated expiration: 2030-12-30

Abstract

The utility model discloses an aerosol generating system and inflammation therapeutic apparatus. The aerosol generating system comprises a discharge unit, a fluid unit and a mixing cavity; the discharging unit comprises a discharging generator, a voltage conveying device and a voltage releasing port which are connected in sequence; the voltage release port is located in the mixing cavity; the fluid unit comprises a storage device and a fluid flow chamber; a fluid release port is arranged on the storage device, and the side wall of the fluid flow chamber is communicated with the storage device through the fluid release port; one end of the fluid flowing chamber is provided with an air inlet, and the other end of the fluid flowing chamber is communicated with the mixing cavity. The system provided by the utility model has the efficient anti-inflammatory effect that disinfects, and the reagent use amount is still less, and the cost is lower, and can weaken the toxicity harm of bacteriostat itself.

Description

Aerosol generating system and inflammation therapeutic apparatus

Technical Field

The utility model relates to the field of medical equipment, concretely relates to aerosol generating system and inflammation therapeutic instrument.

Background

In life, people are often plagued with infectious inflammations caused by biological pathogens such as bacteria, viruses, rickettsia, mycoplasma, fungi and parasites, and the pain and itching caused by these inflammations severely disturb people's lives.

At present, the method for treating the inflammation is the most effective method for eliminating pathogenic bacteria at the affected part of the inflammation in time besides oral anti-inflammatory drugs. Wherein, the mode of directly coating bacteriostatic agent can be adopted to eliminate pathogenic bacteria at the inflammatory affected part. Meanwhile, the specific surface area of the anti-inflammatory effect can be obviously increased by the mode of applying the medicine in a non-direct contact gasification mode. However, the wide use of bacteriostatic agents leads to an increase in the resistance of bacteria, and thus, the desired antibacterial effect cannot be obtained with the passage of time.

SUMMERY OF THE UTILITY MODEL

To the above-mentioned problem that prior art exists, the utility model provides an aerosol takes place system and inflammation therapeutic instrument. The utility model discloses an aerosol generating system can produce the anion through gas such as ionized air or oxygen, can ionize gaseous state or liquid bacteriostat simultaneously, obtains the mixed aerosol of ionized bacteriostat and anion to realize the efficient antiphlogistic effect of disinfecting through the two synergism, the effect that can reach when this synergism is superior to one of them exclusive use.

The utility model discloses a first aspect provides an aerosol generating system, which comprises a discharge unit, a fluid unit and a mixing cavity;

the discharging unit comprises a discharging generator, a voltage conveying device and a voltage releasing port which are connected in sequence; the voltage release port is located in the mixing cavity;

the fluid unit comprises a storage device and a fluid flow chamber; a fluid release port is arranged on the storage device, and the side wall of the fluid flow chamber is communicated with the storage device through the fluid release port; one end of the fluid flowing chamber is provided with an air inlet, and the other end of the fluid flowing chamber is communicated with the mixing cavity.

According to some embodiments of the aerosol generating system of the present invention, the storage device is a gaseous bacteriostatic agent container and/or a liquid bacteriostatic agent container.

According to some embodiments of the aerosol generating system of the present invention, when the storage device is a liquid bacteriostatic agent container, the fluid release port is an atomizer head. The atomizer nozzle can disperse the liquid bacteriostatic agent into tiny liquid drops, and the tiny liquid drops are convenient to be subsequently input into the mixing cavity and ionized.

According to some embodiments of the aerosol generating system of the present invention, when the storage device is a gaseous bacteriostatic agent container, the fluid release port is a gas release port.

According to some embodiments of the aerosol generating system of the present invention, the discharge generator is a corona discharge generator, and the discharge generator is connected to an external power source. Further preferably, the corona discharge generator includes a circuit integration box, be provided with anodal power input line and negative pole power input line on the circuit integration box, anodal power input line and negative pole power input line respectively with the power is connected, realizes the circuit intercommunication.

According to some embodiments of the aerosol generating system of the present invention, the voltage transmission device is a high voltage output wire.

According to some embodiments of aerosol generation system, the mixing cavity is made by non-conductor material, the electric field that produces when can avoiding the voltage release port to discharge is via mixing cavity conduction. Preferably, the preparation material of the mixing cavity is selected from at least one of polyvinyl fluoride, nylon and organic glass.

In accordance with some embodiments of the aerosol generating system of the present invention, the system further comprises a fluid transport device, the fluid flow chamber is in communication with the mixing chamber through the fluid transport device.

According to some embodiments of the aerosol generating system of the present invention, the aerosol generating system further comprises an air pump, the air pump being in communication with the air inlet.

According to some embodiments of the aerosol generating system of the present invention, the system further comprises an aerosol nozzle, the aerosol nozzle is disposed on the mixing chamber.

According to a preferred embodiment of the aerosol generating system of the present invention, the air inlet is connected to the fluid flow chamber through a first joint, and the fluid flow chamber is connected to the fluid delivery device through a second joint.

The utility model provides a discharge unit is behind the switch on, and the gas generation anion around the electric field ionization that produces through the voltage release port, simultaneously, also can come the ionization by the fluid of fluid flow room input as ionization source to mix in mixing the cavity, and then obtain the mixed aerosol of ionized fluid and anion.

In a specific embodiment of the present invention, a corona discharge generator is used as the discharge generator, and the liquid bacteriostatic agent and/or the gaseous bacteriostatic agent are/is selected for use as the fluid. In this embodiment, the corona discharge generator can also serve as an ion source to ionize the bacteriostatic agent in addition to generating negative ions. Therefore, under the dual function of the corona discharge generator, the ionized bacteriostatic agent and the negative ions can be simultaneously generated and mixed to form the aerosol. The mixed aerosol has the sterilization effect of the two. In addition, the ionized bacteriostatic agent can obviously improve the efficacy of the bacteriostatic agent, and the principle is as follows: compared with non-charged bacteriostats, ionized bacteriostats can be more easily attached and captured by bacteria due to electrostatic action; ionized bacteriostatic agents tend to form a hydrated layer around them, e.g., molecules encapsulated by the hydrated layer tend to penetrate the outer membrane of gram-negative bacteria (lower phospholipid content) more readily, contacting the inner membrane of the bacteria (i.e., cytoplasmic membrane) and lysing the inner membrane to kill the bacteria, whereas the outer membrane of gram-negative bacteria is a barrier to normal bacteriostatic agents (lipid soluble).

The utility model discloses in, the antibacterial process of ionization bacteriostat and anion is not isolated going on, exists synergism between the antibacterial bacteriostatic process of the two, and this synergism is superior to the effect that two one of them material can independent play, and then can utilize the bacteriostat of less dose to realize higher bactericidal efficiency. In the different embodiments of the present invention, when the aerosol generating system is used for treating inflammation, the aerosol generating system has high sterilizing efficiency, and can save the amount of the bacteriostatic agent, thereby saving the cost and weakening the toxicity harm caused by the bacteriostatic agent.

The utility model also provides an aerosol generating method who carries out according to foretell aerosol generating system, the method includes following step:

step A, activating the fluid release port to release fluid, wherein the fluid is sent into the fluid flow chamber through the side wall of the fluid flow chamber;

b, gas is fed into the fluid flow chamber from the gas inlet, and the gas carries the fluid into the mixing cavity;

and step C, starting the discharge generator, wherein the voltage release port generates an electric field in the mixing cavity.

According to some embodiments of the above method, the fluid is a gaseous bacteriostatic agent and/or a liquid bacteriostatic agent. The utility model discloses an among the different embodiments, do not restrict the type of gaseous bacteriostat and liquid bacteriostat, can be according to the pathogenic bacterium of difference, select different gaseous bacteriostat and liquid bacteriostat.

According to some embodiments of the above method, when liquid bacteriostatic agent is selected, the fluid delivery port is preferably an atomizer head, such that the liquid bacteriostatic agent disperses into tiny droplets for subsequent input into the mixing chamber and ionization.

According to some embodiments of the above method, the gaseous bacteriostatic agent is preferably ozone and/or a volatile essential oil. The liquid bacteriostatic agent is preferably ethanol and/or quaternary ammonium salt.

In different embodiments of the utility model, different bacteriostats can be selected according to different bacteriostat purposes. For example, alcohol-based organic bacteriostatic agents such as ethanol, which are most commonly used as ethanol with a mass concentration of 75%, can remove lipid substances in the biofilm of pathogenic bacteria and denature proteins. Moreover, the quaternary ammonium salt bacteriostatic agent can adsorb pathogenic bacteria microorganisms with negative charges, destroy cell wall structures of the microorganisms, and cause contents in the microorganisms to leak out, and meanwhile, the quaternary ammonium salt bacteriostatic agent also has the effects of inhibiting activities of pathogenic bacteria oxidase and dehydrogenase.

According to some embodiments of the above method, the gas is oxygen and/or nitrogen. Preferably, the gas is a mixed gas of oxygen and nitrogen. Further preferably, the volume ratio of oxygen in the mixed gas of oxygen and nitrogen is 28%. In some embodiments of the present invention, the type of gas introduced is not limited, and the gas may be air from the viewpoint of cost and realizability.

According to some embodiments of the above method, the mixing chamber is made of a non-conductive material, so that an electric field generated when the voltage release port discharges can be prevented from being conducted through the mixing chamber. Preferably, the preparation material of the mixing cavity is selected from at least one of polyvinyl fluoride, nylon and organic glass.

According to some embodiments of the above method, the electric field local strength is ≧ 20 kV/cm. In the utility model discloses an in the different embodiments, do not restrict the input voltage of discharge generator, because the electric field is inhomogeneous electric field, as long as can satisfy that electric field local strength is more than or equal to 20 kV/cm.

The utility model discloses in, after gas was inputed the air inlet by the air pump, in getting into the fluid flow room via the air inlet, gas carried the fluid wherein and gets into in the mixed cavity. In the mixing cavity, after the discharge generator is started, a voltage release port at the tail end releases a strong electric field in the mixing cavity to ionize the surrounding gas to generate negative ions, and meanwhile, the strong electric field can also be used as an ionization source to ionize fluid in the mixing cavity, so that mixed aerosol of the ionized fluid and the negative ions is obtained.

In one embodiment of the present invention, the fluid is selected from a gaseous bacteriostatic agent and/or a liquid bacteriostatic agent, so that the method has the effects of sterilization and inflammation diminishing. The mixed aerosol obtained in the embodiment is an ionized bacteriostatic agent and negative ion mixed aerosol, and has high-efficiency sterilization and anti-inflammation capabilities.

In the utility model, the discharge generator adopts a corona discharge generator. After the corona discharge generator is powered on, a voltage release port at the tail end of the corona discharge generator generates a strong electric field to ionize nearby gas, wherein the gas can be air or high-purity gas input by a gas pump, or mixed gas of the air and at least one high-purity gas.

The specific ionization process is as follows: the strong electric field of the voltage release port can cause free electrons in the air to violently collide with oxygen molecules to generate oxygen free radicals^-And superoxide radical. O₂ ^-The reaction process is shown as formula (1) and formula (2):

e+O₂＝·O^-+O (1)

·O^-+O₂＝·O₂ ^-+O (2)

oxygen radical O^-And superoxide radical. O₂ ^-Can continue to react with NO in the air₂And CO₂Reaction to produce NO₃ ^-、HCO₃ ^-、CO₃ ^-And CO₄ ^-. In addition, the negative ions generated by this process attract the positive polarity ends of free water molecules (i.e., hydrogen atoms) in the air to form hydrates, such as: CO 2₃ ^-·H₂O、HCO₃ ^-·H₂O、NO₃ ^-·H₂O and CO₄ ^-·H₂And O. For convenience of description, n is used in the present invention^-Denotes the general term of the negative ion, i.e. n^-Is O^-、·O₂ ^-、NO₃ ^-、CO₃ ^-、HCO₃ ^-、CO₄ ^-、CO₃ ^-·H₂O、HCO₃ ^-·H₂O、NO₃ ^-·H₂O and CO₄ ^-·H₂And O and other negative ions.

The process of ionizing bacteriostatic agent molecules (M) by a corona generator is shown as formula (3):

e+M＝M^- (3)

non-energetic free electrons are captured by bacteriostatic molecules to form ions M^-. Also, M^-Hydrates M may also be formed^-·H₂O。

According to some embodiments of the above method, n is^-And M^-·H₂The aerosol formed by the O mixture can permeate the cell outer membrane of gram-negative bacteria to reach the cell inner membrane of the bacteria. Specifically, the antibacterial mechanism of the mixed aerosol is as follows: (1) acting on protease or other bioactive substances required by biochemical reaction. (2) Acting on the genetic material DNA or other genetic microparticulate structure. (3) Acting on the biological membrane system or cell wall. The utility model discloses in not restricting the kind of bacterium, in the different embodiments of the utility model, to the bacterial of different grade type, can select different bacteriostats to the pertinence.

The ionized bacteriostatic agent can also have the antibacterial effect of negative ions.

In some embodiments of the present invention, the antibacterial mechanism of the negative ion against gram-positive bacteria is as follows:

(n^-＝O₂ ^-，CO₃ ^-，HCO₃ ^-，CO₄ ^-，CO₃ ^-·H₂O，HCO₃ ^-·H₂o, etc.)

Reaction formula (4) and reaction formula (5)

First, the negative ions tend to attack the carbonyl groups on the tetrapeptide chains and pentaglycine bridges, which constitute the main framework of the cell wall of pathogenic bacteria, as in the processes shown in equations (4) and (5). During this reaction, the anion n-interacts with the C ═ O bond through nucleophilic addition to produce a tetrahedral intermediate, i.e., the product of reaction formula (4), which then decomposes, cleaving the peptide bond, and the process of reaction formula (5) occurs.

The pathogenic bacterial cell wall skeleton is then broken, leaving only the glycan skeleton, which means that the pathogenic bacterial protective layer has been destroyed, making the cell more fragile. Subsequently, the negative ion n-further attacks the intracellular membrane by cell transfer. Subsequently, the reaction between the negative ion and the cell membrane also occurs on the phospholipid molecule. Among them, phospholipid molecules are essential components for stabilizing the membrane structure. Reaction of formula (6), anion n, occurs by nucleophilic addition^-Attack of the O group results in the loss of the ester bond, and reaction (7) occurs.

At the same time, the negative ion n^-It is also easy to attack the phosphate bond P ═ O on intracellular membrane phospholipids, resulting in reaction formula (8), and after its adduct, the backbone is decomposed, resulting in reaction formula (9).

(R＝C₁₅H₃₁，R′＝C₁₇H₃₃，n^-＝O₂ ^-，CO₃ ^-，HCO₃ ^-，CO₄ ^-，CO₃ ^-·H₂O，HCO₃ ^-·H₂O, etc.)

Reaction formula (6) and reaction formula (7)

Reaction formula (8) and reaction formula (9)

The utility model discloses in, the antibacterial process of ionization bacteriostat and anion is not isolated going on, exists synergism between the antibacterial bacteriostatic process of the two, and this synergism is superior to the effect that two one of them material can independent play. In various embodiments of the present invention, when the aerosol generating method is used for treating inflammation, the aerosol generating method has high sterilization efficiency, and can save the usage amount of the bacteriostatic agent, thereby saving the cost and weakening the toxicity hazard caused by the bacteriostatic agent.

In a second aspect, the present invention provides an inflammation therapy apparatus comprising the above aerosol generating system.

According to some embodiments of inflammation therapeutic instrument, still include belt cleaning device in the therapeutic instrument, belt cleaning device has washing liquid entry, washing liquid runner and washing liquid shower nozzle.

According to some embodiments of the inflammation therapy apparatus of the present invention, the apparatus further comprises a drying device having a dry gas inlet, a dry gas flow channel and a dry gas spray head.

The utility model discloses in, belt cleaning device and drying device can be used for cleaning and drying the affected part around the treatment, the effect of assurance anti-inflammatory sterilization that can be better to reduce the probability of infecting the relapse.

According to some embodiments of the inflammation therapy apparatus of the present invention, the apparatus further comprises a control device, the control device comprises a motor, a rotating screw, and a translation stage. Wherein the aerosol spray head, the cleaning liquid spray head and the dry air spray head are arranged on the translation carrying platform. The motor is electrically connected with the rotating screw and used for controlling the rotating screw to rotate, the rotating screw is used for controlling the translation stage to translate, and the translation stage is used for switching the aerosol spray head, the cleaning liquid spray head and the dry air spray head to work.

According to some embodiments of the inflammation therapy apparatus of the present invention, the control device further comprises a frame for fixing the motor, the rotating screw, and the translation stage.

The utility model discloses in not restriction controlling means's type, for example, the utility model provides a controlling means chooses automatically controlled translation platform for use, automatically controlled translation platform can be according to the demand self-control processing, also can purchase from the producer and have had the product. For example, the electrically controlled translation stage may be purchased from FUYU, electrically controlled linear rail slide, available from yokoyu technologies, inc, with the specific model FSL 80.

According to some embodiments of the inflammation therapeutic apparatus of the present invention, the therapeutic apparatus further comprises an assembly cavity, the aerosol generating system, the cleaning device, the drying device and the control device are disposed in the assembly cavity, an opening is disposed at one end of the assembly cavity, and the translation stage is disposed under the opening.

The utility model provides an inflammation therapeutic instrument produces the mixed aerosol of ionized bacteriostat and anion through aerosol generating system, carries out the inflammation treatment to the affected part, through the rotation of rotatory screw rod among the controlling means, and then switches aerosol shower nozzle, washing liquid shower nozzle and the dry gas shower nozzle on the translation microscope carrier and carry out work in turn, realizes disinfecting respectively diminishing inflammation, washing and dry function.

The utility model discloses an among the concrete implementation mode, if the inflammation affected part has when the unclean thing, can switch to belt cleaning device earlier and wash the affected part, then switch to drying device again and carry out the drying, and all will accompany the drying process after the action of washing finishes at every turn, then switch to the aerosol shower nozzle and disinfect the inflammation to the affected part, later wash and drying process again, and after disinfecting the inflammation action at every turn, all will accompany washing and drying process, and then realize efficient antiphlogistic efficiency of disinfecting, save the use amount of bacteriostatic agent, weaken the toxicity harm that bacteriostatic agent itself brought, the cost is saved, and, realize the relapse infection of minimum probability through washing and drying process.

The utility model also provides an application of above-mentioned aerosol generating system or foretell inflammation therapeutic instrument in local inflammation therapeutic instrument, preferably in gynaecology's inflammation therapeutic instrument and/or haemorrhoids anus inflammation therapeutic instrument. But is not limited thereto.

The utility model has the advantages that:

1. the utility model discloses the antibiotic process of the produced ionized bacteriostat of system and the mixed aerosol of anion is not isolated going on, has the synergism between the antibiotic bacteriostatic process of the two, and the effect when this synergism is superior to the effect when two one of them material acts on alone can realize more extensive antibacterial effect.

2. The utility model provides a when the mixed aerosol of ionized bacteriostat and anion is used for the inflammation treatment, have more efficient bactericidal efficiency, more save the use amount of bacteriostat to save the expense, and weaken the toxicity harm that the bacteriostat itself brought.

3. The utility model provides an inflammation therapeutic instrument adopts aerosol generating system, belt cleaning device and drying device to carry out the integrated processing to the affected part, can realize the relapse infection of minimum probability.

Drawings

Fig. 1 is a schematic structural diagram of an aerosol generating system provided in embodiment 1 of the present invention.

Fig. 2 is a schematic structural diagram of an aerosol generating system according to embodiment 2 of the present invention.

Fig. 3 is a schematic structural diagram of an aerosol generating system according to embodiment 3 of the present invention.

Fig. 4 is a schematic structural view of an inflammation therapeutic apparatus provided in embodiment 4 of the present invention.

Fig. 5 is a schematic structural diagram of a control device, a cleaning device, a drying device and a circuit device in an inflammation therapeutic apparatus according to embodiment 4 of the present invention.

Description of reference numerals:

1. the device comprises an assembly cavity, 2, a control device, 3, an aerosol generating system, 4, a cleaning device, 5, a drying device and 6, a circuit device;

201. a motor 202, a rotating screw 203, a frame 204 and a translation carrier;

311. positive power input line, 312, negative power input line, 313, circuit integrated box, 314, high voltage output wire, 315, voltage release port;

321. an air inlet, 322, a first interface, 323, a fluid flow chamber, 324, a second interface, 325, a fluid delivery device, 326, a mixing chamber, 327, an aerosol spray head;

331. liquid bacteriostatic agent container, 332, atomizer spray head;

341. a gaseous bacteriostatic agent container 342, a gas release port;

401. a cleaning liquid inlet 402, a third interface 403, a cleaning liquid flow passage 404, a fourth interface 405, a cleaning liquid spray head;

501. a dry gas inlet 502, a fifth interface 503, a dry gas channel 504, a sixth interface 505, a dry gas spray head;

601. power adapter, 602, wire.

Detailed Description

In order to make the invention easier to understand, the invention will be described in detail below with reference to the attached drawings and examples, which are only illustrative and not limiting.

The utility model discloses used equipment as follows:

(1) the electric control translation table is a FUYU electric numerical control linear guide rail sliding table of Chengdu Fuyu science and technology limited company, and the model is FSL 80.

(2) The corona discharge generator is the product in CN 201710285159.6.

[ example 1 ]

As shown in fig. 1, a schematic structural diagram of an aerosol generating system provided in this embodiment includes a discharge unit, a fluid unit, and a mixing cavity 326. Wherein the mixing chamber 326 is made of teflon.

The discharge unit includes a positive power input line 311, a negative power input line 312, a circuit integration box 313, a high voltage output wire 314, and a voltage release port 315. The positive power input line 311 and the negative power input line 312 are provided on the circuit integration box 313 for external power supply. The circuit integration box 313 and the voltage release port 315 are connected by a high voltage output wire 314. The voltage discharge port 315 is located in the mixing cavity 326 and is used for discharging a strong electric field after being energized and ionizing air and other gases therein to generate negative ions.

The fluid unit includes a liquid bacteriostatic agent container 331, a gaseous bacteriostatic agent container 341, and a fluid flow chamber 323. The liquid bacteriostatic agent container 331 is provided with an atomizer 332 for dispersing the liquid bacteriostatic agent into tiny droplets. The gaseous bacteriostatic agent container 341 is provided with a gas release port 342. The side wall of the fluid flow chamber 323 communicates with the liquid bacteriostatic agent container 331 and the gaseous bacteriostatic agent container 341 through the atomizer head 332 and the gas discharge port 342, respectively. Also, one end of the fluid flow chamber 323 is provided with an air inlet 321, and the other end communicates with the mixing chamber 326 via a fluid transfer device 325. The air inlet 321 is externally connected to an air pump (not shown), the air inlet 321 is connected to the fluid flow chamber 323 through a first joint 322, and the fluid flow chamber 323 is connected to the fluid delivery device 325 through a second joint 324.

The atomized liquid bacteriostatic agent sprayed from the liquid bacteriostatic agent container 331 and the gaseous bacteriostatic agent sprayed from the gaseous bacteriostatic agent container 341 are input into the mixing cavity 326 through the fluid conveying device 325, and are ionized under the action of the strong electric field released from the voltage release port 315 to obtain an ionized bacteriostatic agent, so as to generate a mixed aerosol with negative ions. The mixed aerosol is sprayed out through the aerosol nozzle 327 to sterilize and diminish inflammation of the affected part.

[ example 2 ]

As shown in fig. 2, the present embodiment has the same structure as the aerosol generating system of embodiment 1, except that: in this embodiment, the liquid bacteriostatic agent container 331 and the atomizer head 332 are not provided.

[ example 3 ]

As shown in fig. 3, the present embodiment has the same structure as the aerosol generating system of embodiment 1, except that: in this embodiment, the gaseous bacteriostatic agent container 341 and the gas release port 342 are not provided.

[ example 4 ]

As shown in fig. 4, a schematic structural diagram of an inflammation therapeutic apparatus provided in this embodiment includes an assembly cavity 1, a control device 2, an aerosol generating system 3, a cleaning device 4, a drying device 5, and a circuit device 6. The structure of the aerosol generating system is the same as that described in embodiment 1, and is not described herein.

As shown in fig. 5, the cleaning device 4 includes a cleaning liquid inlet 401, a cleaning liquid flow passage 403, and a cleaning liquid ejection head 405, wherein the cleaning liquid inlet 401 and the cleaning liquid flow passage 403 are connected by a third interface 402, and the cleaning liquid flow passage 403 and the cleaning liquid ejection head 405 are connected by a fourth interface 404.

The drying device 5 has a drying air inlet 501, a drying air flow channel 503 and a drying air nozzle 505, wherein the drying air inlet 501 and the drying air flow channel 503 are connected by a fifth interface 502, and the drying air flow channel 503 and the drying air nozzle 505 are connected by a sixth interface 504.

The control device 2 in this embodiment selects an electric control translation stage, where the electric control translation stage includes a motor 201, a rotating screw 202, a frame 203, and a translation stage 204. Frame 203 is used to hold motor 201, rotating screw 202, and translation stage 204. The translation stage 204 is provided with an aerosol spray head 327, a cleaning liquid spray head 405 and a dry gas spray head 505. The motor 201 is electrically connected with the rotating screw 202 and is used for controlling the rotating screw 202 to rotate, and the rotating screw further controls the translation carrying platform 204 to translate, so that the aerosol spray head 327, the cleaning liquid spray head 405 and the dry air spray head 505 are switched to work in turn.

The circuit arrangement 6 comprises a power adapter 601 and a cord 602 connected thereto for providing power to the inflammation therapy device.

As shown in fig. 4, the aerosol-generating system 3, the cleaning device 4, the drying device 5, the control device 2 and the circuit device 6 are all disposed in the assembly chamber 1. Moreover, one end of the assembly cavity 1 is opened, and the translation carrying table 204 is positioned right below the opening, so that the materials in the aerosol spray head 327, the cleaning liquid spray head 405 and the dry gas spray head 505 can be sprayed to the affected part.

[ example 5 ]

This example provides an aerosol generating system of example 1 for use in a gram negative bacteria sterilization process, comprising the steps of:

step A, adopting a liquid ethanol bacteriostatic agent with the mass concentration of 75%, spraying atomized ethanol from an atomizer nozzle 332, and feeding the atomized ethanol into a fluid flow chamber 323.

And step B, feeding mixed gas of oxygen and nitrogen with the volume ratio of 28% into the fluid flow chamber 323 through the air inlet 321 by the air pump, and carrying atomized ethanol into the mixing cavity 326.

And step C, switching on the circuit integration box 313, and generating a corona-starting electric field with the local electric field intensity of 20kV/cm in the mixing cavity 326 by the voltage release port 315.

Under the action of the strong electric field, the atomized ethanol is subjected to ionization reaction to obtain ionized ethanol, and oxygen is subjected to negative ion reaction to obtain oxygen radical O^-And superoxide radical. O₂ ^-The negative ions are mixed in the mixing chamber 326 to obtain a mixed aerosol, and the mixed aerosol is used for treating pathogens.

To sum up, the utility model provides an aerosol generation system and inflammation therapeutic instrument have efficient anti-inflammatory effect that disinfects, can effectively solve because the problem that the pathogenic bacteria drug resistance that the bacteriostat used widely leads to improves, and have more extensive antibacterial effect, the reagent use amount still less, and the cost is lower, and can weaken the toxicity harm of bacteriostat itself to show the probability that reduces recurrent infection.

What has been described above is merely a preferred example of the present invention. It should be noted that other equivalent variations and modifications can be made by those skilled in the art based on the technical teaching provided by the present invention, and the protection scope of the present invention should be considered.

Claims

1. An aerosol generating system, comprising a discharge unit, a fluid unit, and a mixing chamber;

the discharging unit comprises a discharging generator, a voltage conveying device and a voltage releasing port which are connected in sequence; the voltage relief port is located within the hybrid cavity;

2. An aerosol generating system according to claim 1, wherein the storage means is a gaseous bacteriostatic agent container and/or a liquid bacteriostatic agent container.

3. An aerosol generating system according to claim 1 or 2, wherein the fluid release port is an atomizer head.

4. An aerosol generating system according to claim 1 or 2, wherein the discharge generator is a corona discharge generator, the discharge generator being externally powered; and/or the presence of a gas in the gas,

the voltage transmission device is a high-voltage output wire; and/or the presence of a gas in the gas,

the mixing chamber is made of a non-conductive material.

5. An aerosol generating system according to claim 1 or 2, further comprising a fluid transport device, wherein the fluid flow chamber is in communication with the mixing chamber via the fluid transport device; and/or the presence of a gas in the gas,

the system also comprises an air pump which is communicated with the air inlet; and/or the presence of a gas in the gas,

the system also comprises an aerosol spray head, and the aerosol spray head is arranged on the mixing cavity; and/or the presence of a gas in the gas,

the air inlet is connected with the fluid flow chamber through a first joint, and the fluid flow chamber is connected with the fluid conveying device through a second joint.

6. An inflammation therapy device comprising an aerosol generating system according to any one of claims 1 to 5.

7. The inflammation therapy device of claim 6, further comprising a cleaning device having a cleaning fluid inlet, a cleaning fluid flow path, and a cleaning fluid spray head; and/or the presence of a gas in the gas,

the therapeutic apparatus also comprises a drying device which is provided with a dry air inlet, a dry air flow channel and a dry air nozzle.

8. The inflammation therapy apparatus of claim 7, further comprising a control device, wherein the control device comprises a motor, a rotating screw, and a translation stage; wherein, an aerosol spray head, the cleaning liquid spray head and the dry air spray head are arranged on the translation carrying platform; the motor is electrically connected with the rotating screw and used for controlling the rotating screw to rotate, the rotating screw is used for controlling the translation stage to translate, and the translation stage is used for switching the aerosol spray head, the cleaning liquid spray head and the dry air spray head to work.

9. The inflammation therapy apparatus of claim 8, wherein the control device further comprises a frame for securing the motor, the rotating screw, and the translation stage.

10. The inflammation therapy apparatus according to claim 9, further comprising an assembly chamber, wherein the aerosol generating system, the cleaning device, the drying device and the control device are disposed in the assembly chamber, one end of the assembly chamber is open, and the translation stage is disposed directly below the opening.